Stockscreener 앱 받기
3.66
1.67%
0.06
Immucell Corp 주식(ICCC)의 최신 뉴스
ImmuCell Q3 Earnings Decline Y/Y, Sales Grow Amid Margin Challenges - MSN
ImmuCell Third Quarter 2024 Earnings: US$0.086 loss per share (vs US$0.12 loss in 3Q 2023) - Yahoo Finance
ImmuCell Corporation (NASDAQ:ICCC) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: ImmuCell reports recovery and strong demand for Q3 2024 - Investing.com
ICCCImmucell Corp Latest Stock News & Market Updates - StockTitan
ImmuCell Q3 Sales Jump 11% to $6M, Nine-Month Revenue Surges 51% Despite Net Loss | ICCC Stock News - StockTitan
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 - StockTitan
ImmuCell reports 11% sales boost in third quarter - Investing.com
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024 - StockTitan
ImmuCell amends lease terms and by-laws - Investing.com
Healthcare Stock Performance - Yahoo Finance
IMMUCELL CORP- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
ImmuCell Second Quarter 2024 Earnings: US$0.20 loss per share (vs US$0.18 loss in 2Q 2023) - Yahoo Finance
ImmuCell Corporation (NASDAQ:ICCC) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: ImmuCell reports growth amid operational challenges - Investing.com
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024 - StockTitan
ImmuCell (ICCC) Scheduled to Post Earnings on Wednesday - Defense World
ImmuCell stock touches 52-week low at $3.92 amid market challenges - Investing.com
ImmuCell Corp hits 52-week low, trading at $4.05 - Investing.com
PriceSmart, Kura Sushi And 3 Stocks To Watch Heading Into Wednesday - Benzinga
ImmuCell reports robust sales growth in Q2 2024 - Investing.com
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 - StockTitan
ImmuCell (NASDAQ:ICCC) Stock Price Crosses Below Two Hundred Day Moving Average of $4.95 - Defense World
ImmuCell says Pfizer terminates contract on Mast Out - Reuters.com
Short Interest in ImmuCell Co. (NASDAQ:ICCC) Expands By 66.7% - Defense World
Rollins (NYSE:ROL) Upgraded to “Buy” at StockNews.com - Defense World
VBI Vaccines (NASDAQ:VBIV) Now Covered by Analysts at StockNews.com - Defense World
Immucell updates status of product development initiative for Re-TainTipRanks.com - TipRanks
ImmuCell progresses with FDA regulatory process for cattle health product By Investing.com - Investing.com Australia
ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain® - GlobeNewswire Inc.
ImmuCell progresses with FDA regulatory process for cattle health product - Investing.com
ImmuCell Corporation (NASDAQ:ICCC) Q1 2024 Earnings Call Transcript - Insider Monkey
Earnings call: ImmuCell reports sales increase to $7.2 million - Investing.com South Africa
Earnings call: ImmuCell reports sales increase to $7.2 million By Investing.com - Investing.com UK
ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript - Seeking Alpha
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024 - Investing.com India
3 Magnificent S&P 500 Dividend Stocks Down 17% to 44% to Buy and Hold Forever - The Motley Fool
After-hours movers: SMART Global, PriceSmart, and more By Investing.com - Investing.com
Breeding innovation: Rarebreed grows out of Maine’s animal-health hub - Mainebiz
Bovine Mastitis Treatment System Market Analysis : US, Germany, France, India, ChinaForecast 2024-2028 - Technavio
Top 20 Animal Health Companies in the World - Insider Monkey
Today's Gap Up Stocks | Find Top Stocks Gapping Up Today - MarketBeat
‘Unleashing’ growth: Maine's emerging ‘Silicon Valley for animal health’ - Mainebiz
Democrat Jacky Rosen sees Big Pharma investments soar while urging lower drug prices - Washington Examiner
ImmuCell achieves USDA approval of new product claim - Feedstuffs
Jim Grasky named to senior role at Olympia Snowe Women's Leadership Institute - Press Herald
No. 1 in the Northeast: Maine startup business is region’s fastest-growing, says Inc. - Press Herald
UMass Amherst Allows Maine-based ImmuCell Corp. the Right to License New Bacteriocin Technology - UMass News and Media Relations
Biotechnology now employs nearly 10,000 workers in Maine - Press Herald
ImmuCell plans second expansion in three years as demand grows - Mainebiz
Portland-based biotech ImmuCell posts 45% sales increase for Q4 - Mainebiz
ImmuCell Corp (ICCC) CEO Michael Brigham Q4 2021 Results Earnings Call Transcript - Seeking Alpha
Today's Death Cross Stocks - MarketBeat
Portland's ImmuCell targeted by New York law firm over FDA setback - Press Herald
38 Stocks Moving In Tuesday's Mid-Day Session - Markets Insider
Guidance Calendar as of Oct 9th - Benzinga
Portland-based ImmuCell reports sales increase, advances toward product release - Mainebiz
The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPOiShares ... - Benzinga
ImmuCell (NASDAQ:ICCC) Stock Quotes, Forecast and News Summary - Benzinga
ImmuCell receives $500,000 loan from Maine Technology Institute - Press Herald
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The SpotlightiShares - Benzinga
Here Are the Companies Getting Federal Covid Relief Funds - Bloomberg
The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rock - Benzinga
0.93%
3.55%
자본화:
|
볼륨(24시간):